Jump to content

Bucumolol

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by The Nth User (talk | contribs) at 01:01, 23 July 2019 (References: Replaced two categories with subcategory). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Bucumolol
Names
IUPAC name
8-[3-(tert-Butylamino)-2-hydroxypropoxy]-5-methylchromen-2-one
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
KEGG
MeSH C024221
UNII
  • InChI=1S/C17H23NO4/c1-11-5-7-14(16-13(11)6-8-15(20)22-16)21-10-12(19)9-18-17(2,3)4/h5-8,12,18-19H,9-10H2,1-4H3
    Key: CIJVBYRUFLGDHY-UHFFFAOYSA-N
  • InChI=1/C17H23NO4/c1-11-5-7-14(16-13(11)6-8-15(20)22-16)21-10-12(19)9-18-17(2,3)4/h5-8,12,18-19H,9-10H2,1-4H3
    Key: CIJVBYRUFLGDHY-UHFFFAOYAD
  • CC1=C2C=CC(=O)OC2=C(C=C1)OCC(CNC(C)(C)C)O
Properties
C17H23NO4
Molar mass 305.374 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Bucumolol is a beta-adrenergic antagonist.[1]

References

[edit]
  1. ^ Nakayama, K; Oshima, T; Koike, H (1981). "Assessment of beta-blockade and the non-specific effect of bucumolol, a beta-adrenergic blocking agent, on atrioventricular conduction in anesthetized dogs". Archives Internationales de Pharmacodynamie et de Thérapie. 254 (1): 145–56. PMID 6121536.